The successful candidate will contribute to the discovery, characterization, and preclinical evaluation of these targeted degraders using immortalized erythroid cell lines, primary human erythroblasts, and sickle cell disease mouse models, with the long-term objective of advancing promising therapeutic candidates toward clinical development. The Associate Scientist will work closely with Senior Scientists, postdoctoral fellows, and cross-functional teams of medicinal chemists, molecular and cellular biologists, biochemists, and structural biologists in a highly collaborative, team-based research environment.